Skip to content
PICO Portalanswers from OpenAlex

S2915 Back to the Basics: Use Of Budesonide as the Treatment for Immune Checkpoint Inhibitor Induced Microscopic Colitis Non-Responsive to Prednisone, Infliximab, and Vedolizumab

PaperCitations, authors & open-access status

S2915 Back to the Basics: Use Of Budesonide as the Treatment for Immune Checkpoint Inhibitor Induced Microscopic Colitis Non-Responsive to Prednisone, Infliximab, and Vedolizumab is a paper indexed in PICO Portal from OpenAlex.

How many citations does S2915 Back to the Basics: Use Of Budesonide as the Treatment for Immune Checkpoint Inhibitor Induced Microscopic Colitis Non-Responsive to Prednisone, Infliximab, and Vedolizumab have?

PICO Portalcitation count

S2915 Back to the Basics: Use Of Budesonide as the Treatment for Immune Checkpoint Inhibitor Induced Microscopic Colitis Non-Responsive to Prednisone, Infliximab, and Vedolizumab has 2 citations in the OpenAlex counts PICO Portal stores.

When was S2915 Back to the Basics: Use Of Budesonide as the Treatment for Immune Checkpoint Inhibitor Induced Microscopic Colitis Non-Responsive to Prednisone, Infliximab, and Vedolizumab published?

PICO Portalyear

S2915 Back to the Basics: Use Of Budesonide as the Treatment for Immune Checkpoint Inhibitor Induced Microscopic Colitis Non-Responsive to Prednisone, Infliximab, and Vedolizumab has 2024 year in the PICO Portal index.

What is the open-access status of S2915 Back to the Basics: Use Of Budesonide as the Treatment for Immune Checkpoint Inhibitor Induced Microscopic Colitis Non-Responsive to Prednisone, Infliximab, and Vedolizumab?

PICO Portaloa status

S2915 Back to the Basics: Use Of Budesonide as the Treatment for Immune Checkpoint Inhibitor Induced Microscopic Colitis Non-Responsive to Prednisone, Infliximab, and Vedolizumab has closed oa status in the PICO Portal index.

What is the DOI of S2915 Back to the Basics: Use Of Budesonide as the Treatment for Immune Checkpoint Inhibitor Induced Microscopic Colitis Non-Responsive to Prednisone, Infliximab, and Vedolizumab?

PICO Portaldoi

The DOI for S2915 Back to the Basics: Use Of Budesonide as the Treatment for Immune Checkpoint Inhibitor Induced Microscopic Colitis Non-Responsive to Prednisone, Infliximab, and Vedolizumab is on the source record.

What is the OpenAlex record for S2915 Back to the Basics: Use Of Budesonide as the Treatment for Immune Checkpoint Inhibitor Induced Microscopic Colitis Non-Responsive to Prednisone, Infliximab, and Vedolizumab?

PICO Portalopenalex

The OpenAlex for S2915 Back to the Basics: Use Of Budesonide as the Treatment for Immune Checkpoint Inhibitor Induced Microscopic Colitis Non-Responsive to Prednisone, Infliximab, and Vedolizumab is on the source record.

Related on PICO Portal

470M+ articles · 14-day free trial